The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.

The t(9;14)(p13;q32) translocation is associated with approximately 50% of lymphoplasmacytoid lymphoma (LPL), a subtype of B-cell non-Hodgkin's lymphoma (NHL). We cloned the chromosomal breakpoint of der (14) from an LPL case (1052) and showed that it involved a junction between 9p13 and the switch micro region of the Ig heavy chain locus (IgH) on 14q32. Using a YAC contig spanning 1.5 megabase (Mb), we determined that the 9p13 breakpoint in one case (1052) mapped within a 270-kb restriction fragment containing two previously reported 9p breakpoints associated with a alpha-heavy chain disease case (MAL) and KI-1 positive diffuse large cell lymphoma (DLCL) cell line (KIS-1). The same fragment also contained the PAX-5 gene which encodes a B-cell specific transcription factor involved in the control of B-cell proliferation and differentiation. The breakpoints of KIS-1 and 1052 were mapped within the 5' noncoding region of PAX-5, while the 9p13 breakpoint of MAL mapped 230 to 270 kb upstream to PAX-5. In all three cases, the translocation caused the juxtaposition of the PAX-5 gene to the IgH locus in the opposite direction of transcription. When compared with six other DLCL cell lines lacking t(9;14)(p13;q32), the KIS-1 cell line showed an 11-fold overexpression of PAX-5 mRNA and a significantly reduced expression of the p53 gene, which is normally regulated by PAX-5. Moreover, metaphase and interphase fluorescence in situ hybridization (FISH) analysis using a YAC clone spanning 1 Mb including the PAX-5 as a probe identified chromosomal translocations in 5 of 7 cases carrying 9p13 translocations. These findings suggest that the PAX-5 gene is the target of the t(9;14) in LPL whereby its expression may be deregulated by juxtaposition to IgH regulatory elements, thus contributing to lymphomagenesis.

[1]  C. Croce,et al.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[2]  P. Nowell,et al.  Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. , 1984, Science.

[3]  J. Sklar,et al.  Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Korsmeyer,et al.  Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18 , 1985, Cell.

[5]  M. Kozak.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.

[6]  Y. Ohtsuki,et al.  Characterization of a new human lymphoma cell line (RC‐K8) with t(11;14) chromosome abnormality , 1986, Cancer.

[7]  P. Pelicci,et al.  Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Minden,et al.  The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor. , 1987, Blood.

[9]  H. Ohno,et al.  A Novel B Cell Line Established from Ki‐1‐positive Diffuse Large Cell Lymphoma , 1988, Japanese journal of cancer research : Gann.

[10]  S. Korsmeyer,et al.  Alternative promoters and exons, somatic mutation and deregulation of the Bcl‐2‐Ig fusion gene in lymphoma. , 1988, The EMBO journal.

[11]  R. Berger,et al.  Molecular analysis of a t(9;14)(p11;q32) translocation occurring in a case of human alpha heavy chain disease. , 1989, Oncogene.

[12]  T. Shows,et al.  Molecular analysis of a chromosomal translocation, t(9;14)(p13;q32), in a diffuse large-cell lymphoma cell line expressing the Ki-1 antigen. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Riley,et al.  A novel, rapid method for the isolation of terminal sequences from yeast artificial chromosome (YAC) clones. , 1990, Nucleic acids research.

[14]  Fred Winston,et al.  Methods in Yeast Genetics: A Laboratory Course Manual , 1990 .

[15]  O. Melnyk,et al.  Characterization of a candidate bcl-1 gene , 1991, Molecular and cellular biology.

[16]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[17]  K Offit,et al.  t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. , 1992, Blood.

[18]  M. Eccles,et al.  Expression of the PAX2 gene in human fetal kidney and Wilms' tumor. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[19]  A. Aguzzi,et al.  Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. , 1992, Genes & development.

[20]  Pavel Urbánek,et al.  Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9 , 1993, Nature Genetics.

[21]  K. Offit,et al.  Clusters of chromosome 9 aberrations are associated with clinico‐pathologic subsets of non‐Hodgkin's lymphoma , 1993, Genes, chromosomes & cancer.

[22]  P Gruss,et al.  The oncogenic potential of deregulated homeobox genes. , 1993, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[23]  G. Gaidano,et al.  Subregional localization of 20 single-copy loci to chromosome 6 by fluorescence in situ hybridization. , 1993, Genomics.

[24]  M. Busslinger,et al.  Alternative splicing of Pax-8 gene transcripts is developmentally regulated and generates isoforms with different transactivation properties , 1993, Molecular and cellular biology.

[25]  Y. Akao,et al.  Molecular Cloning of 19p13 Breakpoint Region in Infantile Leukemia with t(11;19)(q23;p13) Translocation , 1993, Japanese journal of cancer research : Gann.

[26]  B. Emanuel,et al.  Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma , 1993, Nature Genetics.

[27]  K Offit,et al.  Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. , 1993, Science.

[28]  E. E. Max,et al.  The B cell-specific transcription factor BSAP regulates B cell proliferation , 1994, The Journal of experimental medicine.

[29]  E. Wagner,et al.  Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5 BSAP , 1994, Cell.

[30]  J. Biegel,et al.  Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. , 1994, Cancer research.

[31]  M. Eccles,et al.  Alternative messenger RNA forms and open reading frames within an additional conserved region of the human PAX-2 gene. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[32]  L. Madisen,et al.  Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. , 1994, Genes & development.

[33]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[34]  Ian Krop,et al.  E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements , 1994, Cell.

[35]  K. Offit,et al.  Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Gruss,et al.  PAX genes: what's new in developmental biology and cancer? , 1995, Human molecular genetics.

[37]  B cell differentiation: role of E2A and Pax5/BSAP transcription factors. , 1995, Oncogene.

[38]  P. Gruss,et al.  Loss of p53 function through PAX‐mediated transcriptional repression. , 1995, The EMBO journal.